Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-01

Clinical Trial Update: Impact of Discontinuing Hypertonic Saline in People With CF on Highly Effective CFTR Modulators- A SIMPLIFY Sub-Study [NA]

View source ↗

Summary

A SIMPLIFY sub-study evaluated the effects of discontinuing hypertonic saline in people with cystic fibrosis who are on highly effective CFTR modulators.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Nicole Hamblett | Conditions: Cystic Fibrosis | NA | Status: COMPLETED | Results posted: 2024-10-01